Affiliation:
1. Département de Psychiatrie et de Médecine Addictologique Hôpital Fernand Widal, APHP Paris France
2. Université Paris Cité UMR‐S 1144 Therapeutic Optimization in Neuropsychopharmacology INSERM Paris France
3. FHU NOR‐SUD (Network of Research in Substance Use Disorders) APHP Paris France
4. FRONT‐Lab ICM Institut du Cerveau INSERM Paris France
5. Service de Neuroradiologie Fondation Ophtalmologique Rothschild Paris France
6. Clermont Auvergne INP CHU Clermont‐Ferrand CNRS Institut Pascal Université Clermont Auvergne Clermont‐Ferrand France
7. Service de Pharmacie à Usage Interne Hôpital Fernand Widal, APHP Paris France
Abstract
AbstractBackground and ObjectivesCocaine is a highly addictive substance, and with no approved medication for cocaine use disorder (CUD), leading to a heavy burden. Despite validated psychosocial treatments, relapse rates after detoxification are very high in CUD. Few consistent factors can predict abstinence after detoxification. Our study, therefore, aimed at identifying factors predicting abstinence among CUD patients after inpatient detoxification.MethodsEighty‐one CUD inpatients were included during detoxification and characterized for clinical and sociodemographic data at baseline and at a follow‐up of 3 months after discharge, including a standard measure of their abstinence duration from cocaine. We performed Cox univariate analyzes to determine the factors associated with abstinence maintenance, followed by a multivariate Cox regression to identify independent predictors.ResultsAbstinence maintenance was shorter in patients injecting cocaine (hazard ratio [HR] = 5.16, 95% confidence interval [CI]: 2.01–13.27, p < .001) and using cocaine heavily in the month before inclusion (HR = 1.03, 95% CI: 1.00–1.06, p = .046). Conversely, abstinence maintenance was longer in patients with longer inpatient detoxification stays (HR = 0.96, 95% CI: 0.94–0.99, p = .015) and prescribed with selective serotonin reuptake inhibitors (SSRIs) (HR = 0.30, 95% CI: 0.16–0.56, p < .001).Discussion and ConclusionsPatients with severe CUD may require longer inpatient stays to achieve abstinence. Regarding SSRI prescription, more specific studies are needed to provide stronger recommendations about their use in clinical practice.Scientific SignificanceOur findings suggest several modifiable factors to improve inpatient treatment response in CUD. As there are no specific recommendations about the optimal duration of inpatient stay, our results could pave the way for evidence‐based guidelines.
Reference30 articles.
1. UNODC. World Drug Report 2022. Published online2022.
2. From First Drug Use to Drug Dependence Developmental Periods of Risk for Dependence upon Marijuana, Cocaine, and Alcohol
3. European Monitoring Centre for Drugs and Drug Addiction.European Drug Report 2022: Trends and Developments. Publications Office;2022. Accessed February 19 2023.doi:10.2810/75644
4. Mortality among cocaine users: A systematic review of cohort studies
5. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Reference Life Table. Published online2021.doi:10.6069/1D4Y-YQ37
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献